Primary Orthostatic Tremor supports researchers conducting scientific studies and clinical trials to improve diagnosis, understand disease mechanisms, and advance therapies for this rare movement disorder.
Funder: National Organization for Rare Disorders
Due Dates: January 19, 2027, at 11:59 p.m. PT (Initial application / Letter of intent)
Funding Amounts: One grant up to $50,000 USD for a one- or two-year project
Summary: Supports scientific and clinical research on primary orthostatic tremor to improve diagnosis, understand disease mechanisms, and advance therapies.
Key Information: Open to U.S. and international researchers; strong preference for faculty-level or senior scientists at academic or nonprofit institutions or foundations.
The National Organization for Rare Disorders (NORD), supported by donations from the Primary Orthostatic Tremor community, funds scientific and clinical studies related to this rare movement disorder. Primary orthostatic tremor causes rapid leg tremor while standing, often accompanied by unsteadiness or imbalance, and its cause remains unknown.
Offered through NORD’s Rare Disease Research Grants Program, established in 1989, this opportunity supports the initiation of research studies or clinical trials that improve diagnosis, understanding of underlying disease mechanisms, or therapy. The aim is to generate results that can attract further funding from the NIH, FDA, other funding agencies, or corporate sponsors. Ideally, the proposed work will have the potential to lead to a new or better therapy.